These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. What can chronic arthritis pain teach about developing new analgesic drugs? Witter J; Dionne RA Arthritis Res Ther; 2004; 6(6):279-81. PubMed ID: 15535840 [TBL] [Abstract][Full Text] [Related]
63. Multimodal pain management in veterinary medicine: the physiologic basis of pharmacologic therapies. Lamont LA Vet Clin North Am Small Anim Pract; 2008 Nov; 38(6):1173-86, v. PubMed ID: 18954679 [TBL] [Abstract][Full Text] [Related]
65. Recent progress in the pharmacotherapy of cancer pain. Mercadante S Expert Rev Anticancer Ther; 2001 Oct; 1(3):487-94. PubMed ID: 12113115 [TBL] [Abstract][Full Text] [Related]
66. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Kissin I Anesth Analg; 2010 Mar; 110(3):780-9. PubMed ID: 20185657 [TBL] [Abstract][Full Text] [Related]
68. A benefit-risk assessment of caffeine as an analgesic adjuvant. Zhang WY Drug Saf; 2001; 24(15):1127-42. PubMed ID: 11772146 [TBL] [Abstract][Full Text] [Related]
69. Chronic pain. Considering the role of medication. Mayo Clin Health Lett; 2001 Jan; 19(1):4-5. PubMed ID: 11201531 [No Abstract] [Full Text] [Related]
70. Neuropathic pain in dogs and cats: if only they could tell us if they hurt. Mathews KA Vet Clin North Am Small Anim Pract; 2008 Nov; 38(6):1365-414, vii-viii. PubMed ID: 18954689 [TBL] [Abstract][Full Text] [Related]
71. [Pain-killing agents in serious diseases with severe pain]. Naess K Tidsskr Nor Laegeforen; 1968 May; 88(10):972-5. PubMed ID: 5686813 [No Abstract] [Full Text] [Related]
72. Pharmacological FMRI in the development of new analgesic compounds. Schweinhardt P; Bountra C; Tracey I NMR Biomed; 2006 Oct; 19(6):702-11. PubMed ID: 16986120 [TBL] [Abstract][Full Text] [Related]
73. Utilizing brain imaging for analgesic drug development. Borsook D; Ploghaus A; Becerra L Curr Opin Investig Drugs; 2002 Sep; 3(9):1342-7. PubMed ID: 12498011 [TBL] [Abstract][Full Text] [Related]
74. [Pharmacology of pain in older persons]. Pickering G Psychol Neuropsychiatr Vieil; 2006 Jun; 4(2):95-102. PubMed ID: 16753582 [TBL] [Abstract][Full Text] [Related]
75. Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? Cardinaletti C; Mattioli L; Ghelfi F; Del Bello F; Giannella M; Bruzzone A; Paris H; Perfumi M; Piergentili A; Quaglia W; Pigini M J Med Chem; 2009 Nov; 52(22):7319-22. PubMed ID: 19886609 [TBL] [Abstract][Full Text] [Related]
76. The pitfalls of profoundly effective analgesic therapies. Clark JD Clin J Pain; 2008; 24(9):825-31. PubMed ID: 18936601 [TBL] [Abstract][Full Text] [Related]
77. Biologics: the next generation of analgesic drugs? Chessell IP; Dudley A; Billinton A Drug Discov Today; 2012 Aug; 17(15-16):875-9. PubMed ID: 22464946 [TBL] [Abstract][Full Text] [Related]
78. Topical analgesic agents. McCleane G Clin Geriatr Med; 2008 May; 24(2):299-312, vii. PubMed ID: 18387457 [TBL] [Abstract][Full Text] [Related]
79. [What is certain in pain therapy? The analgesic potency of neuroleptics in the treatment of chronic pain. A metaanalysis]. Nix WA Schmerz; 1998 Feb; 12(1):30-8. PubMed ID: 12799990 [TBL] [Abstract][Full Text] [Related]
80. Management strategies for neuropathic pain in different European countries. Krajnik M; McCrory C; Allen S J Pain Palliat Care Pharmacother; 2007; 21(2):49-52. PubMed ID: 17844727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]